{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T08:32:37Z","timestamp":1774945957767,"version":"3.50.1"},"reference-count":24,"publisher":"Medknow","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pathol Microbiol"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/ijpm.ijpm_726_17","type":"journal-article","created":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T09:09:41Z","timestamp":1554887381000},"page":"256","source":"Crossref","is-referenced-by-count":5,"title":["Distribution of common BCR-ABL fusion transcripts and their impact on treatment response in Imatinib treated CML patients: A study from India"],"prefix":"10.4103","volume":"62","author":[{"given":"Renu","family":"Saxena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudha","family":"Sazawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunita","family":"Chhikara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanwaljeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rekha","family":"Chaubey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoranjan","family":"Mahapatra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tulika","family":"Seth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2581","reference":[{"key":"key-10.4103\/0377-4929.255842-1","first-page":"990","volume-title":"The molecular genetics of Philadelphia chromosome positive leukemias","author":"Kurzrock","year":"1988","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0377-4929.255842-2","first-page":"90","volume-title":"Chronic myelogenous leukemia: Disease biology and current and future therapeutic strategies","author":"Kantarjian","year":"2000","journal-title":"Hematology"},{"key":"key-10.4103\/0377-4929.255842-3","first-page":"3343","volume-title":"The molecular biology of chronic myeloid leukemia","author":"Deininger","year":"2000","journal-title":"Blood"},{"key":"key-10.4103\/0377-4929.255842-4","first-page":"26","volume-title":"Incidence of BCR-ABL transcript variants in patients with chronic myeloid leukemia: Their correlation with presenting features, risk scores and response to treatment with Imatinib Mesylate","author":"Deb","year":"2014","journal-title":"Indian J Med Paediatr Oncol","ISSN":"https:\/\/id.crossref.org\/issn\/0971-5851","issn-type":"print"},{"key":"key-10.4103\/0377-4929.255842-5","first-page":"42","volume-title":"Cytogenetic and molecular analyses in adult chronic myelogenous leukaemia patients in north India","author":"Anand","year":"2012","journal-title":"Indian J Med Res","ISSN":"https:\/\/id.crossref.org\/issn\/0971-5916","issn-type":"print"},{"key":"key-10.4103\/0377-4929.255842-6","first-page":"247","volume-title":"Frequency of BCR-ABL fusion transcripts in Iranian patients with chronic myeloid leukemia","author":"Yaghmaie","year":"2008","journal-title":"Arch Iran Med"},{"key":"key-10.4103\/0377-4929.255842-7","first-page":"845","volume-title":"Molecular profiling of chronic myeloid leukemia in eastern India","author":"Mondal","year":"2006","journal-title":"Am J Hematol"},{"key":"key-10.4103\/0377-4929.255842-8","first-page":"249","volume-title":"Comprehensive analysis of BCR-ABL transcript types in Korean CML patients using a newly developed multiplex RT-PCR","author":"Goh","year":"2006","journal-title":"Transl Res"},{"key":"key-10.4103\/0377-4929.255842-9","first-page":"193","volume-title":"Relationship of the BCR gene breakpoint and the type of BCR\/ABL transcript to clinical course, prognostic indexes and survival in patients with chronic myeloid leukemia","author":"Prejzner","year":"2002","journal-title":"Med Sci Monit"},{"key":"key-10.4103\/0377-4929.255842-10","first-page":"1138","volume-title":"Analysis and comparison of clinic-hematological parameters and molecular and cytogenetic response of two BCR\/ABL fusion transcripts","author":"Polampalli","year":"2008","journal-title":"Genet Mol Res"},{"key":"key-10.4103\/0377-4929.255842-11","first-page":"1939","volume-title":"Better molecular response to Imatinib for patients (pts) with chronic myeloid leukemia (CML) in chronic phase (CP) carrying the b3a2 transcript compared to b2a2","author":"Vega-Ruiz","year":"2007","journal-title":"Blood"},{"key":"key-10.4103\/0377-4929.255842-12","first-page":"4780","volume-title":"b2a2 Type BCR-ABL transcript chronic myelogenous leukemia (CML) patients in chronic phase (CP) on Glivec achieve complete cytogenetic remission (CCyR) earlier than those with b3a2","author":"Lomaia","year":"2006","journal-title":"Blood"},{"key":"key-10.4103\/0377-4929.255842-13","first-page":"546","volume-title":"Analysis of molecular breakpoint and m-RNA transcripts in a prospective randomized trial of interferon in chronic myeloid leukaemia: No correlation with clinical features, cytogenetic response, duration of chronic phase, or survival","author":"Shepherd","year":"1995","journal-title":"Br J Haematol"},{"key":"key-10.4103\/0377-4929.255842-14","first-page":"1441","volume-title":"Distinct characteristics of e13a2versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with Imatinib","author":"Hanfstein","year":"2014","journal-title":"Haematologica"},{"key":"key-10.4103\/0377-4929.255842-15","first-page":"1230","volume-title":"BCR-ABL fusion transcript do not significantly influence the outcome of chronic myeloid leukemia patients in early chronic phase treated with imatinib Mesylate: A GIMEMA CML WP analysis","author":"Castagnetti","year":"2010","journal-title":"ASH Annual Meeting Abstracts"},{"key":"key-10.4103\/0377-4929.255842-16","first-page":"1362","volume-title":"Chronic myeloid leukemia patients with the e13a2 BCR-ABL fusion transcript have inferior responses to Imatinib compared to patients with the e14a2 transcript","author":"Lucas","year":"2009","journal-title":"Haematologica"},{"key":"key-10.4103\/0377-4929.255842-17","first-page":"811","volume-title":"Differential molecular response of the transcripts B2a2 and B3a2 to Imatinib Mesylate in chronic myeloid leukemia","author":"de","year":"2005","journal-title":"Genet Mol Res"},{"key":"key-10.4103\/0377-4929.255842-18","first-page":"28","volume-title":"Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: Review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results","author":"Hughes","year":"2006","journal-title":"Blood"},{"key":"key-10.4103\/0377-4929.255842-19","first-page":"2318","volume-title":"Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - A Europe Cancer Program","author":"Gabert","year":"2003","journal-title":"Leukemia"},{"key":"key-10.4103\/0377-4929.255842-20","unstructured":"Ries LAG, Harkins D, Krapcho M, SEER Cancer Statistics Review, 1975-2003. Bethesda: National Cancer Institute; 2006."},{"key":"key-10.4103\/0377-4929.255842-21","first-page":"64","volume-title":"A comprehensive analysis of breakpoint cluster region-abelson fusion oncogene splice variants in chronic myeloid leukemia and their correlation with disease biology","author":"Iqbal","year":"2014","journal-title":"Indian J Hum Genet","ISSN":"https:\/\/id.crossref.org\/issn\/0971-6866","issn-type":"print"},{"key":"key-10.4103\/0377-4929.255842-22","first-page":"1395","volume-title":"The possible influences of B2A2 and B3A2 BCR\/ABL protein structure on thrombopoiesis in chronic myeloid leukaemia","author":"Perego","year":"2000","journal-title":"Eur J Cancer"},{"key":"key-10.4103\/0377-4929.255842-23","first-page":"666","volume-title":"Younger age and shorter chronic phase in b2a2-positive chronic myeloid leukemia adults with high white blood cell count at diagnosis","author":"Mart\u00ednez-Mancilla","year":"2002","journal-title":"Haematologica"},{"key":"key-10.4103\/0377-4929.255842-24","first-page":"839","volume-title":"The location of the Philadelphia chromosomal breakpoint site and prognosis in chronic granulocytic leukemia","author":"Tefferi","year":"1990","journal-title":"Leukemia"}],"container-title":["Indian Journal of Pathology and Microbiology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T09:13:05Z","timestamp":1554887585000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ijpmonline.org\/text.asp?2019\/62\/2\/256\/255842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"alternative-id":["255842"],"URL":"https:\/\/doi.org\/10.4103\/ijpm.ijpm_726_17","relation":{},"ISSN":["0377-4929"],"issn-type":[{"value":"0377-4929","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}